"The marker identified by researchers—telomeric allelic imbalance—has the potential to predict whether a patient with triple-negative breast cancer will respond to platinum-based chemotherapy..."
http://www.cancernetwork.com/triple-negative-breast-cancer/content/article/10165/2054305
(click link for full story)
http://www.cancernetwork.com/triple-negative-breast-cancer/content/article/10165/2054305
(click link for full story)